about
Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic interventionThe Bicyclic Intermediate Structure Provides Insights into the Desuccinylation Mechanism of Human Sirtuin 5 (SIRT5)Nuclear export modulates the cytoplasmic Sir2 homologue Hst2.Resveratrol inhibits β-amyloid-induced neuronal apoptosis through regulation of SIRT1-ROCK1 signaling pathwayResveratrol improves cardiac contractility following trauma-hemorrhage by modulating Sirt1Proteolipid protein is required for transport of sirtuin 2 into CNS myelinSirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease.PLMLA: prediction of lysine methylation and lysine acetylation by combining multiple features.Nutrition and prevention of Alzheimer's dementia.Phytic acid as a potential treatment for alzheimer's pathology: evidence from animal and in vitro models.Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons.The redox basis of epigenetic modifications: from mechanisms to functional consequences.Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects.Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies.Effect of Trans-resveratrol on Rotenone-induced Cytotoxicity in Human Breast Adenocarcinoma CellsDiscriminating between lysine sumoylation and lysine acetylation using mRMR feature selection and analysis.Differential expression of sirtuins in the aging rat brainMitochondrial medicine for aging and neurodegenerative diseasesMitochondria as a therapeutic target for aging and neurodegenerative diseases.Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.Expression of SIRT1 and DBC1 in Developing and Adult RetinasConcurrent Treatment with Taxifolin and Cilostazol on the Lowering of β-Amyloid Accumulation and Neurotoxicity via the Suppression of P-JAK2/P-STAT3/NF-κB/BACE1 Signaling Pathways.Cell Life versus cell longevity: the mysteries surrounding the NAD+ precursor nicotinamide.Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design.Life span extension and neuronal cell protection by Drosophila nicotinamidase.Natural antisense transcripts are co-expressed with sense mRNAs in synaptoneurosomes of adult mouse forebrainProtein folding and aggregation into amyloid: the interference by natural phenolic compoundsNatural antioxidants in Alzheimer's disease.Chemical mechanisms of histone lysine and arginine modificationsMitochondrial structural and functional dynamics in Huntington's disease.AMPK and the biochemistry of exercise: implications for human health and disease.HDAC inhibitors and neurodegeneration: at the edge between protection and damage.Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases.Plant polyphenols: chemical properties, biological activities, and synthesis.Potential of chromatin modifying compounds for the treatment of Alzheimer's disease.Brain activation of SIRT1: role in neuropathology.Role of SIRT1 in autoimmune demyelination and neurodegeneration.Gene regulation and genetics in neurochemistry, past to future.Alzheimer's Disease: From Mitochondrial Perturbations to Mitochondrial Medicine.Cilostazol suppresses β-amyloid production by activating a disintegrin and metalloproteinase 10 via the upregulation of SIRT1-coupled retinoic acid receptor-β.
P2860
Q26865358-D9E2614C-98C3-4962-9D8E-4D786F03406EQ27670648-450E2446-2719-442B-8FFC-CC118A336FE2Q27934693-85CE3E4D-F5CD-417A-AD11-1B699FEE97EAQ28489106-E9620B03-1FFA-418E-9566-F68310925B92Q28567865-8AB4AA4E-1E21-404B-9D7A-D63912753C16Q28587657-598B9850-09A0-40B3-BE74-2EF4DC25DD3CQ33619317-CC97FBE7-1FD4-4C76-B679-182A3B7EE1CFQ34259740-F72750D8-769D-4F51-88CF-6B0D47FC6341Q34369234-8A35D605-489E-4B5D-A044-C204D2F466AAQ34490302-FB40F387-4BEB-4E02-BC6D-1661782961B7Q34772619-022BECD0-D948-4479-B6AD-EA299DDAD931Q35055739-EB49DDF7-2DEC-4F47-BA9F-FA977CAE9004Q35059268-1D535341-F8F4-4DC4-A0B6-F1ED72851F96Q35140660-A43123E4-7173-4587-A1D8-5BC41B80302DQ35245122-69D9D40A-CDA8-4AED-919D-063BBB54D592Q35253001-C6593A7A-C876-4893-9608-7C300D058A42Q35584969-F8B2243A-6DB0-4E04-9A14-7F53FA02BAC1Q35606693-636E5D44-9119-40C6-B325-FC3A8757273DQ35807409-B3B09A5F-EF0C-4ED5-BBD4-631F855C4A0BQ35958359-3C343459-7515-46C3-92BC-E727200AF522Q36219702-5B93FFC0-919F-4AB9-80CB-254F8C5EBF6AQ36225127-A31EC712-6B09-4C67-BFF9-CE9DD9AD2596Q36447198-7C599BA8-B79B-49C8-8EE5-106D5CDFC1D8Q36908436-57D1BD7F-3133-4972-BF94-D8794358DEF0Q36924185-267BCB87-346B-44C5-9A1D-C630BEBBFF6EQ37004147-A747061A-9E96-4D26-894C-E3C34CA0D950Q37007345-2DA5B0D3-3067-4771-9C5F-FD7177D14A89Q37016092-09056301-FB55-46CD-9393-FB9D619AC6C2Q37097824-AF2F6FA9-FBDB-4D91-A9A5-27571C6668E7Q37356257-68B4AF06-140E-4D5A-B2D6-DF2494B1AFD5Q37386321-157BE61A-7E5A-40B1-9093-8ED380C99493Q37685428-AE8320C1-E913-4943-8973-2CAF72012340Q37689874-CDECA461-AE13-431F-8937-484E059177CDQ37827837-688A1A5E-86D6-43C3-8C9F-9331DC342194Q38041123-C9D78587-A395-475C-951F-98A98E541B40Q38101493-AFA12915-7BC9-487F-9FF5-FEE5B37E8ED1Q38256576-AFEE5E5B-3B90-4800-9A23-1F5C445EA1A1Q38802501-7ECF8B48-BC54-4D02-A0D8-A339CD324AFBQ38872085-649A2C2A-B13D-4C45-8A62-24675DC91416Q38987753-C7799E7A-A89A-4FEE-8704-39F063996028
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Neuronal protection by sirtuins in Alzheimer's disease.
@ast
Neuronal protection by sirtuins in Alzheimer's disease.
@en
type
label
Neuronal protection by sirtuins in Alzheimer's disease.
@ast
Neuronal protection by sirtuins in Alzheimer's disease.
@en
prefLabel
Neuronal protection by sirtuins in Alzheimer's disease.
@ast
Neuronal protection by sirtuins in Alzheimer's disease.
@en
P1476
Neuronal protection by sirtuins in Alzheimer's disease.
@en
P2093
P Hemachandra Reddy
Thimmappa S Anekonda
P304
P356
10.1111/J.1471-4159.2005.03492.X
P407
P577
2005-10-07T00:00:00Z